These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. The insulin-antagonistic effect of the counterregulatory hormones--clinical and mechanistic aspects. Smith U; Attvall S; Eriksson J; Fowelin J; Lönnroth P; Wesslau C Adv Exp Med Biol; 1993; 334():169-80. PubMed ID: 8249681 [No Abstract] [Full Text] [Related]
12. [Insulin and glucagon. Recent discoveries, problems and questions concerning their biosynthesis, secretion and mode of action]. Stauffacher W Schweiz Med Wochenschr; 1972 Feb; 102(8):245-50. PubMed ID: 4334566 [No Abstract] [Full Text] [Related]
13. Insulin-antagonistic effects of counterregulatory hormones: clinical and mechanistic aspects. Smith U; Lager I Diabetes Metab Rev; 1989 Sep; 5(6):511-25. PubMed ID: 2670491 [No Abstract] [Full Text] [Related]
14. [Secondary forms of diabetes mellitus associated with endocrine diseases]. Borges-Martins L; Betea D; Daly A; Beckers A Rev Med Liege; 2005; 60(5-6):442-7. PubMed ID: 16035309 [TBL] [Abstract][Full Text] [Related]
15. [Diabetes mellitus. I. On the etiopathogenesis of diabetes mellitus]. Bibergeil H Z Arztl Fortbild (Jena); 1969 Jul; 63(13):685-90. PubMed ID: 4903228 [No Abstract] [Full Text] [Related]
16. Hormonal antagonism to insulin and its significance in the diabetic state. Muraleedharam MV; Rastogi GK J Assoc Physicians India; 1977 Oct; 25(10):739-51. PubMed ID: 353027 [No Abstract] [Full Text] [Related]
17. Insulin secretion in obesity: pseudodiabetes? Karam JH; Grodsky GM; Forsham PH Am J Clin Nutr; 1968 Dec; 21(12):1445-54. PubMed ID: 4881680 [No Abstract] [Full Text] [Related]
18. [Diabetes secondary to endocrinolopathies]. Suzuki S Nihon Rinsho; 1996 Oct; 54(10):2709-14. PubMed ID: 8914432 [TBL] [Abstract][Full Text] [Related]